Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
2003 ◽
Vol 13
(Suppl 2)
◽
pp. 144-148
◽
2005 ◽
Vol 15
(3)
◽
pp. 558-560
2009 ◽
Vol 40
(2)
◽
pp. 166-173
◽
Keyword(s):